Simply Good Foods Is Taking a Near-Double-Digit Price Hike and Handing the Proceeds to Consumers

Simply Good Foods closed fiscal 2026 with net sales down 9.7% to $333.3 million and adjusted EBITDA down 13.2% to $57.5 million — modestly ahead of plan, as management kept reminding listeners. Then Chris Bealer delivered the part that mattered: “we expect net sales to decline between 13%-17%” — Chris Bealer, Chief Financial Officer · 2026-10-27 in fiscal 2027, with the first quarter down 19% to 22% and first-quarter EBITDA down 28% to 33%. For a company whose equity has already fallen 78% from its 2022 peak and another 29% from its July high, that is not a soft landing. It is a deliberate second descent, and the odd thing is that management is choosing it.

Take price, then give the price back

The architecture of the FY27 plan is what makes this report worth reading. Simply Good Foods is executing a price increase approaching double digits across much of its portfolio, which is expected to lift gross margin 250-300 basis points — and then it is spending almost all of the gain on marketing. Marketing rises about 90 basis points of sales, selling expense falls slightly, and EBITDA lands down 9% to 14%. Joe Scalzo, who took over during fiscal 2026, framed this as philosophy rather than arithmetic: “Rather than maximizing near-term earnings, we are deliberately reinvesting a meaningful portion of those improvements back into our brands.” — Joe Scalzo, President and CEO · 2026-10-27

The diagnosis behind that decision is the most self-critical language this company has produced in years. Scalzo's summary of the prior regime: “we did not price, we had gross margin erosion, we cut marketing support, we stopped recruiting” — Joe Scalzo, President and CEO · 2026-10-27. The numbers bear him out. Gross margin sat at 32.5% in the last filed quarter, against a 48.1% peak back in 2018 — roughly 15 points of cushion gone, which is precisely the cushion that pays for television, influencers and demo programs. The company's own marketing-mix study, completed in early September, confirmed it:

At the highest level, the return we were experiencing for our marketing well below the midpoint of benchmarks for consumer packaged goods... The third, and most important, is we weren't spending enough money. The returns are a function of marketing pressure. There was not enough marketing pressure.

That is a genuinely fresh piece of company-specific vocabulary — marketing pressure — and it is doing real work in the plan: it is the mechanism by which the price increase is supposed to convert into household penetration rather than into margin. It even rhymes with a global theme this quarter, where marketing pressure surfaced in the market-wide keyword set in the context of it declining. For Simply Good Foods, the wager is that the pressure goes up before the results do.

Elasticity is the entire bet, and it is unhedged

Everything above depends on one number nobody can currently measure. Scalzo was unusually candid about it: “We are at price points we have never been at, so we are using our best estimate of what we believe elasticities are.” — Joe Scalzo, President and CEO · 2026-10-27 Recent smaller increases had run at 1.0x to 1.2x; the plan now assumes “elasticities to be well above one, weighted more heavily to the first half of the year” — Joe Scalzo, President and CEO · 2026-10-27, with some brands crossing key dollar thresholds. Q4 consumption of -8.4% is the base being priced off: Quest -2.1%, OWYN -7.0%, Atkins -22.6%.

This is the second iteration of the same trade. On the July 2026 call Scalzo called pricing “short-term pain for long-term gain” — Joe Scalzo, President and CEO · 2026-07-09 at a high-single-digit level. The number has since grown to "approaching double digits" and the pain has been pushed a full year out. Price points and pricing elasticity have accordingly become the company's most load-bearing language, while the softer framing of a year ago — distribution losses, funnel communication — has slipped out of the top of the keyword stack. What replaced it is consumer-segmentation vocabulary: passionate architects for OWYN, "Performance Maxers" for Quest, consumer fundamentals as the thing that must be rebuilt. That is a real change in how management talks, and it is a better story than the one it replaces.

The second-half inflection, on its second lap

The tension worth flagging is cadence. Simply Good Foods has now promised a second-half recovery three consecutive times, each from a lower base. In January 2026, on Quest bars: “you should start to see the impact of that in the results in the second half.” — Geoff Tanner, President and Chief Executive Officer · 2026-01-08 In July 2026 it was second-half gross margin and an EBITDA inflection. Now it is fiscal 2027's second half — with Scalzo already pointing past it, noting roughly 2-3 points of club rotation headwind that only burns off in the first quarter of fiscal 2028.

The prior call also set out the yardstick investors should use, and it is worth holding management to it: “are our margins improving? ... Because that provides us the fuel we need to drive our top line.” — Joe Scalzo, President and CEO · 2026-07-09 Fiscal 2027 will answer that. Gross margin is guided up 250-300 basis points; the price is a 13-17% sales decline and a double-digit EBITDA decline. If the margin lands and Quest's household penetration (20.2%, up about 50 basis points) starts climbing again, the sequence worked. If the price elasticities come in worse than the admittedly conservative estimate, there is no second lever — OWYN is absorbing six to nine more months of distribution-driven losses, and Atkins is being rebuilt around a narrower consumer.

The GLP-1 reframe is not new, but it is finally specific

Atkins is the wildcard. Management is repositioning it around lapsed and cycling GLP-1 users — roughly 23 million U.S. adults, by their research — with Rob Lowe returning as spokesman. The GLP 1 thread is not a discovery: it has run through this company's keywords since early 2024, and the January 2026 call described a pilot clinical study on patients taking the drug. What is new is the wedge. Rather than competing to help people lose weight, Atkins now sells maintenance — “whether we can get Atkins back in the people recruiting business” — Joe Scalzo, President and CEO · 2026-10-27 — against a weight loss conversation that has moved decisively toward pharmaceuticals. It is a narrower claim and a more defensible one, and it is the only part of this story where the company is aiming at a growing pool rather than defending a shrinking one.

The tape has already voted, and it voted some time ago. Price to revenue is 0.8x against 4.9x in 2019. Price to free cash flow is 11.3x. And the company has been buying its own stock hard into that decline — 11.7 million shares repurchased for about $213 million in fiscal 2026, with $141 million left on the authorization, against net debt of roughly 0.9x EBITDA. Note the base effect: operating margin reads -14.0% in the latest filed quarter, a figure driven by write-downs rather than by the trading business.

The honest read is that this is a small-cap consumer name at 0.8x sales, run by a returning CEO, making an explicit choice to be smaller and less profitable for a year in exchange for a rebuilt brand. That is either the most rational thing a packaged-foods board could do or the most expensive way to discover that price elasticity above one is not a forecast but a fact. The next two quarters — Quest's household penetration, and whether the near-double-digit shelf price holds without promotional giveback — will decide which.